Trinity Biotech Latest News
- 03-14 MarketWatchTrinity Biotech receives non-compliance notice from Nasdaq
- 03-14 NasdaqTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
- 03-14 AInvest WireTrinity Biotech Appoints Barclays Capital as Exclusive Financial Advisor for CGM Technology
- 03-13 MarketWatchTrinity Biotech Advances Strategic Realignment with Barclays Appointment
- 03-13 MarketWatchTrinity Biotech engages Barclays to advise on strategic realignment process
- 02-28 MarketWatchTrinity Biotech Secures Funding for Glucose Monitoring Tech
- 02-28 MarketWatchTrinity Biotech announces additional funding for transformation plan
- 02-26 AInvest WireTrinity Biotech shares fall 2.47% after-hours following Plymouth Industrial REIT's revenue miss.
- 02-25 AInvest WireTrinity Biotech Plc shares fall 3.66% intraday as Richmond Fed's Barkin urges caution in monetary policy.
- 02-24 AInvest WireTrinity Biotech Plc shares rise 5.47% intraday after Constellation Brands gains on Berkshire Hathaway stake.
- 02-18 AInvest WireTrinity Biotech Plc shares rise 4.92% after-hours following strategic acquisitions in aerospace and defense.
- 02-13 AInvest WireTrinity Biotech Plc shares fall 2.50% premarket after Tribal Rides CEO resignation.
- 02-11 AInvest WirePremier Anesthesia Expands Ohio Services with New Partnership
- 02-07 AInvest WireTrinity Biotech shares up 5.00% premarket following AGM notice.
- 02-06 MarketWatchTrinity Biotech’s CGM System Shows Breakthrough Improvements
- 02-06 NasdaqTrinity Biotech Reports Significant Advancements in Continuous Glucose Monitoring System Performance
- 02-06 MarketWatchTrinity Biotech reports findings from latest pre-pivotal trial on CGM system
- 02-06 AInvest WireTrinity Biotech's CGM System Shows 35% Improvement in First-Day Accuracy.
- 02-04 AInvest WireTrinity Biotech shares fall 5.51% intraday after funding announcement.
- 02-03 AInvest WireTrinity Biotech shares fall 4.22% premarket after $81.25M funding.
Show More News